Three Dimensional (3D) Printing is a promising method for quick prototyping and manufacturing of any material.
It is similar to photocopy or printing, where the new materials are formed on layers (3D) like its mother component.
Following its growth and advancement in the 1980s, its application in pharmaceuticals is still limited. It has become one of
the most innovative and influential tools serving as a technology of precise manufacturing of developed dosage forms from
the last decade. The potential of 3D printing to produce drugs for precise measurement customized to specific patients'
needs has shown the possibility of developing personalized medicines to novel dosage forms. The breakthrough allows the
clear perception of the dosage structures on different shapes, sizes, and surfaces challenging to deliver using Designed
conditions. There are different difficulties related to the correct utilization of 3D imprinting in the pharmaceutical Part,
which ought to be defeated to abuse the extent of this technology. Recent advancements in the field of 3D printing
technology used in the pharmaceutical industry mainly focused on different techniques for the fabrication of different
dosage forms. The Food and Drug Administration's (FDA) recent approval of the first 3D prescription highlights
possibilities for 3D printing innovation in the pharmaceutical drug supply field. This analysis assesses 3D printing
advancement possibilities, particularly in the area of custom prescriptions. This technology can be regarded as the future of
demand-produced, low-cost solid dosage forms, and helps minimize side effects due to overdose.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.